|
| View:
Latest News | Top Stories |
|
| Monday, Nov 23, 2009 |
|
| · | Generex Scientist Makes Presentation at National Influenza Congress
GlobeNewswire -
2 hours, 13 minutes ago |
|
| Thursday, Nov 19, 2009 |
|
| · | Should You Buy It? Alkermes
RealMoney by TheStreet.com -
Thu Nov 19 |
|
| · | Delcath Systems Reports Substantial Progress
PR Newswire -
Thu Nov 19 |
|
| Wednesday, Nov 18, 2009 |
|
| · | Our Lady of the Lake Connects Infusion Pumps to the EHR to Help Decrease Errors and Improve Care
GlobeNewswire -
Wed Nov 18 |
|
| · | Delcath Systems share offering raises $32 million
AP -
Wed Nov 18 |
|
| · | Delcath Systems share offering raises $32 million
AP -
Wed Nov 18 |
|
| · | Delcath Systems Announces Completion of Public Offering
PR Newswire -
Wed Nov 18 |
|
| · | Good News for Alkermes' Pipeline
Zacks.com -
Wed Nov 18 |
|
| Tuesday, Nov 17, 2009 |
|
| · | Alkermes Initiates Phase 2 Clinical Study of ALKS 33 for the Treatment of Alcohol Dependence
Business Wire -
Tue Nov 17 |
|
| Monday, Nov 16, 2009 |
|
| · | ULURU Inc. Reports Third Quarter 2009 Financial Results
PR Newswire -
Mon Nov 16 |
|
| · | NovaDel Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2009
Business Wire -
Mon Nov 16 |
|
| · | Flamel Technologies SA Q3 2009 Earnings Call Transcript
at Seeking Alpha -
Mon Nov 16 |
|
| · | Alkermes' Vivitrol succeeds in opiate study
AP -
Mon Nov 16 |
|
| · | NovaDel Signs Exclusive License and Distribution Agreement with Hi-Tech Pharmacal Co., Inc.'s Subsidiary to Commercialize and Manufacture ZolpiMist in the US and Canada
Business Wire -
Mon Nov 16 |
|
| · | Alkermes Announces Positive Results from Phase 3 Clinical Study of Naltrexone for Extended-Release Injectable Suspension for the Treatment of Opioid Dependence
Business Wire -
Mon Nov 16 |
|
| · | Flamel Technologies Announces Third Quarter 2009 Results; Additional New Projects; Cash Increases from $45.1 to $48.8 million
Business Wire -
Mon Nov 16 |
|
| · | Aradigm Doses First Patient in Long-Term Phase 2 Study of a Novel Inhaled Ciprofloxacin Formulation for the Management of Respiratory Infections in Bronchiectasis
Business Wire -
Mon Nov 16 |
|
| · | Delcath Systems to Present at Lazard Capital Markets 6th Annual Healthcare Conference
PR Newswire -
Mon Nov 16 |
|
| Friday, Nov 13, 2009 |
|
| · | Columbia Laboratories Comments on Stock Activity
Business Wire -
Fri Nov 13 |
|
| · | Delcath prices share offering at $3.60 per share
AP -
Fri Nov 13 |
|
|
More Latest News...
|
